AMZN
57
2
ALLE
66
2
GS
63
-2
ADSK
56
-5
GE
71
3
STX
71
-3
ESS
42
-2
VIX
40
-9
OMC
51
-6
BIIB
52
-3
UNM
50
-3
AN
63
2
KMX
58
-2
HBAN
65
-3
TSCO
78
2
PNW
53
3
DD
64
3
CSX
55
11
CHD
40
3
XRAY
46
2
AMZN
57
2
ALLE
66
2
GS
63
-2
ADSK
56
-5
GE
71
3
STX
71
-3
ESS
42
-2
VIX
40
-9
OMC
51
-6
BIIB
52
-3
UNM
50
-3
AN
63
2
KMX
58
-2
HBAN
65
-3
TSCO
78
2
PNW
53
3
DD
64
3
CSX
55
11
CHD
40
3
XRAY
46
2
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Buy
69

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$21.51
Seasonality Move:
-1.84%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 1% based on the past 10 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $21.59. The Score for BBC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 1% based on the past 10 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Buy
69
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.65
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
21.59
Volume:
91.8K
Beta:
1.28

Technical Analysis

SMA50:
19.03
SMA100:
18.95
SMA200:
22.71
52-Wk Change:
-18.04%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 21.59 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-18 19.50 19.58 19.94 19.31
Jun-20 19.75 19.32 19.75 19.02
Jun-23 19.20 19.19 19.37 18.77
Jun-24 19.49 19.84 19.98 19.35
Jun-25 20.09 19.81 20.09 19.35
Jun-26 19.70 19.74 19.74 19.44
Jun-27 19.75 19.41 19.79 19.31
Jun-30 19.49 19.32 19.60 19.31
Jul-1 19.25 19.46 19.96 19.15
Jul-2 19.43 20.19 20.41 19.43
Jul-3 20.27 20.32 20.39 20.08
Jul-7 20.33 19.99 20.33 19.87
Jul-8 20.23 20.33 20.55 20.21
Jul-9 20.61 21.59 21.69 20.61

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.